2026 Next-Gen Innovation & Leadership

• Global premiere of OTESALY® Bodyfill Vial, setting new trends in body max contouring.

2025 Technological Breakthroughs

• Launched the disruptive CaHafill LD and Micro-infusion System Kit.
• Showcased at Dubai Derma and major aesthetic summits in China.

2023 Strategic R&D & Global Expansion

• Initiated PllaHAfill® research to advance biomaterial technology.
• Expanded market influence in Southeast Asia and the Middle East.

2021 Premium Portfolio Expansion

• Official launch of the Jealifill® premium dermal filler series and obtained CE Certification.

2019 Supply Chain & Logistics Excellence

• Introduced the SOMED® product line to the international market.
• Established a USA Logistics Center for efficient global delivery and renewed ISO 13485 Quality Management System certification.

2015 Strategic Entry into Latin America

• Expanded into Brazil and signed strategic regional distribution agreements.
• Expanded international certifications with FDA Compliance.

2013 International Brand Recognition

• Debuted at Cosmoprof Asia (HK).
• Launched the “AIMA Aesthetic Academy” global expert training program.

2006 Clinical Research & Collaboration

• Established a GMP-Certified manufacturing standard in collaboration with First Affiliated Hospital of ZJU and Shanghai Ninth People’s Hospital.

2003 Founding of AIMA

• Established AIMA Co., Ltd. and launched the flagship brand OTESALY®.